Health Care·Life Sciences Tools & Services·$32.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.22 | N/A | +2.52% |
management commentary, guidance changes, and full analysis available with Pro.
| +2.52% |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting their commitment to operational efficiency. However, they did not provide specific guidance for the upcoming quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on maintaining operational efficiency.
Agilent Technologies reported a slight beat on EPS, which indicates that the company is managing its costs effectively. However, the stock fell by 1.84% after the earnings report, suggesting that investors may have been looking for more comprehensive guidance or stronger revenue figures. The lack of revenue data and future guidance may have contributed to the stock's decline.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
FUTU HLDGS LTD ADR
May 28, 2024